| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Cryo-Cell International Inc
Cryo-Cell International Inc
NASDAQ:CCEL
Cryo-Cell International Inc
Cash from Financing Activities
Cryo-Cell International Inc
Cash from Financing Activities Peer Comparison
DVA
DGX
CVS
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cryo-Cell International Inc
NASDAQ:CCEL
|
Cash from Financing Activities
-$761.1k
|
CAGR 3-Years
49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$575.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$1.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$6.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Cryo-Cell International Inc's Cash from Financing Activities?
Cash from Financing Activities
-761.1k
USD
Based on the financial report for Feb 29, 2024, Cryo-Cell International Inc's Cash from Financing Activities amounts to -761.1k USD.
What is Cryo-Cell International Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
2%
The average annual Cash from Financing Activities growth rates for Cryo-Cell International Inc have been 49% over the past three years , and 2% over the past ten years .
You don't have any saved screeners yet
